A Bioactive Compound from Sanguisorba officinalis L. Inhibits Cell Proliferation and Induces Cell Death in 5-Fluorouracil-Sensitive/Resistant Colorectal Cancer Cells

Colorectal cancer (CRC) is one of the most common cancer in the world. The first line chemotherapeutic agent, 5-fluorouracil (5-FU), plays a predominant role in the clinical treatment of CRC. However, with the wide use of 5-FU, more and more CRC patients have been obtaining drug resistance to 5-FU,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weijia, Peng, Chang, Shen, Xue, Yuan, Yuemei, Zhang, Wei, Yang, Chunjuan, Yao, Meicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270258/
https://www.ncbi.nlm.nih.gov/pubmed/34202548
http://dx.doi.org/10.3390/molecules26133843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270258/
https://www.ncbi.nlm.nih.gov/pubmed/34202548
http://dx.doi.org/10.3390/molecules26133843

Ejemplares similares